Pfizer, Starboard Value
Pfizer, GSK
Which COVID vaccine is better? It’s hard to say that one is better than the other. “Antibody studies have shown that the mRNA ...
Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 ...
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
The FDA recently approved the updated mRNA Pfizer and Moderna boosters, as well as the updated Novavax COVID vaccine, to ...
Pfizer Inc. ( PFE, Financial) rose to prominence during the Covid-19 pandemic for its rapid development of a vaccine and ...
Pfizer (PFE) stock may present opportunities for patient investors. Read how this biotech giant may deliver long-term ...
Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and ...
The drugmaker has shed nearly $180 billion in market cap after struggling to chart a new course as the COVID-19 pandemic ...
Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...
As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback